YD Bio Limited Ordinary Shares is a publicly traded company trading on NASDAQ, led by CEO Ethan Shen, with a market cap of $383.3M.
Common questions about YD Bio Limited Ordinary Shares
YD Bio Limited Ordinary Shares is scheduled to report earnings for FY 2025 on April 21, 2026 after market close.
We use cookies for analytics. See our Privacy and Cookie Policy.